| mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
BCL-LZH-4 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.9 |
| mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |